EnsoData and Nonin partner to offer affordable, non-invasive at home sleep testing for patients at risk of sleep apnea, bringing accessible sleep testing and diagnosis to all audiences, including patients with limited access to care
EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea, allowing EnsoData to improve access and affordability in underserved sleep apnea patient populations.
Partnership Announcement: AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription.
Aeroflow and EnsoData usher in a new era in personalized sleep apnea care, population health management, and patient coaching with AI-powered predictive analysis of CPAP monitoring data.
EnsoData announces its FDA-cleared diagnostic AI analysis and sleep scoring solution, EnsoSleep, earned stage-specific autoscoring software certification from the American Academy of Sleep Medicine (AASM).
EnsoData achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices.
EnsoData and React Health announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea using EnsoData’s AI technology.
EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s 2023 List of Best Workplaces, marking third consecutive year on the list.
EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide, a milestone reached in May 2023.
EnsoData has appointed Dr. Nathaniel Watson as New Chief Medical Officer, expanding its clinical sleep expertise.